WallStSmart

Chime Financial, Inc. Class A Common Stock (CHYM)vsServiceNow Inc (NOW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ServiceNow Inc generates 503% more annual revenue ($13.96B vs $2.32B). NOW leads profitability with a 12.6% profit margin vs -41.9%. NOW earns a higher WallStSmart Score of 54/100 (C-).

CHYM

Hold

41

out of 100

Grade: D

Growth: 6.7Profit: 3.5Value: 5.0Quality: 6.5
Piotroski: 2/9Altman Z: -0.66

NOW

Buy

54

out of 100

Grade: C-

Growth: 7.3Profit: 6.0Value: 6.0Quality: 5.0
Piotroski: 1/9Altman Z: 1.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CHYM.

NOWUndervalued (+82.6%)

Margin of Safety

+82.6%

Fair Value

$613.35

Current Price

$112.45

$500.90 discount

UndervaluedFair: $613.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CHYM3 strengths · Avg: 8.7/10
Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

Revenue GrowthGrowth
24.8%8/10

Revenue surging 24.8% year-over-year

NOW4 strengths · Avg: 8.5/10
Market CapQuality
$131.65B9/10

Large-cap with strong market position

Debt/EquityHealth
0.219/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
22.1%8/10

Revenue surging 22.1% year-over-year

Free Cash FlowQuality
$1.53B8/10

Generating 1.5B in free cash flow

Areas to Watch

CHYM4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-67.2%2/10

ROE of -67.2% — below average capital efficiency

EPS GrowthGrowth
-33.8%2/10

Earnings declined 33.8%

Altman Z-ScoreHealth
-0.662/10

Distress zone — elevated risk

NOW4 concerns · Avg: 3.8/10
Price/BookValuation
9.9x4/10

Trading at 9.9x book value

EPS GrowthGrowth
2.3%4/10

2.3% earnings growth

Altman Z-ScoreHealth
1.654/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CHYM

The strongest argument for CHYM centers on Debt/Equity, Operating Margin, Revenue Growth. Revenue growth of 24.8% demonstrates continued momentum.

Bull Case : NOW

The strongest argument for NOW centers on Market Cap, Debt/Equity, Revenue Growth. Revenue growth of 22.1% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : CHYM

The primary concerns for CHYM are Piotroski F-Score, Return on Equity, EPS Growth.

Bear Case : NOW

The primary concerns for NOW are Price/Book, EPS Growth, Altman Z-Score. A P/E of 76.0x leaves little room for execution misses.

Key Dynamics to Monitor

CHYM is growing revenue faster at 24.8% — sustainability is the question.

NOW generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NOW scores higher overall (54/100 vs 41/100) and 22.1% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chime Financial, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Chime Financial, Inc., a financial technology company, provides digital consumer banking and payment solutions. The company is headquartered in San Francisco, California.

ServiceNow Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

ServiceNow is an American software company based in Santa Clara, California that develops a cloud computing platform to help companies manage digital workflows for enterprise operations.

Want to dig deeper into these stocks?